Journal: Journal of Neurotrauma

Article Title: A Systematic Review of Cellular Transplantation Therapies for Spinal Cord Injury

doi: 10.1089/neu.2009.1177

Figure Lengend Snippet: Bone Marrow-Derived Stromal Cells – BMSC – Mesenchymal Stem Cells The stromal cells from the bone marrow are isolated and separated from the hematopoetic cell fraction of the bone marrow by their predilection to adhere to plastic. Some authors exclude the contamination by hematopoetic cells (which are CD 34 positive) by FACS. BMSCs are hence a crude mixture of stromal cells which support the growth of hematopoetic stem cells and mesenchymal stem cells. Some authors provide some additional (somewhat unspecific) markers to characterize these mesenchymal stem cells. Hence the actual stromal versus mesenchymal stem cell nature of the transplanted cells is unclear in many studies.

Article Snippet: Lee Neurop-athology 2003 Model : Adult C57BL/6 mice , 15–20 g Injury : T10 contusion, 0.25 mm at 40 ms using pneumatic impact device ▪ Adherent BMSCs from 5–8 week old C57BL/6 male mice ; 2 nd /3 rd passage; Hoechst 33342 labeled cells suspended in DMEM at 1 × 10 3 cells per μl) and injected directly into (1.5 μl) & 2 mm rostral to the lesion (1.5 μl) @ 1 wk PI • Immunosuppression : None SUBACUTE 1.

Techniques: Isolation, Injection, Labeling, Control, Transplantation Assay, Functional Assay, Modification, Saline, Passaging, IV Injection, Marker, Membrane, Migration, Produced, Western Blot, Clinical Proteomics, Magnetic Resonance Imaging, Immunohistochemistry, Expressing, Suspension, In Vitro, Cell Culture, Ex Vivo, Mouse Assay, Transgenic Assay, Transfection, Sterility, TUNEL Assay, Recombinant, Microscopy, In Vivo, Imaging, Radioactivity, H&E Stain, Staining, In Vivo Imaging, Activity Assay, Immunohistochemical staining, Infection, Light Microscopy, Disruption, Retroviral, Transduction, Enzyme-linked Immunosorbent Assay, Genetically Modified, Plasmid Preparation, Comparison

Journal: Scientific Reports

Article Title: Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation

doi: 10.1038/s41598-018-26515-0

Figure Lengend Snippet: Patient characteristics at time of LVAD implantation.

Article Snippet: All patients received a continuous-flow 3 rd generation LVAD (HVAD Heartware Inc., Framingham, USA) for a severe HF at our institution.

Techniques: Functional Assay

Journal: Scientific Reports

Article Title: Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation

doi: 10.1038/s41598-018-26515-0

Figure Lengend Snippet: Cause of death 30 days after LVAD (total n = 14).

Article Snippet: All patients received a continuous-flow 3 rd generation LVAD (HVAD Heartware Inc., Framingham, USA) for a severe HF at our institution.

Techniques:

Journal: Scientific Reports

Article Title: Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation

doi: 10.1038/s41598-018-26515-0

Figure Lengend Snippet: Retention parameters at LVAD implantation and after 30 days. ( A ) Creatinine. ( B ) BUN. ( C ) eGFR *** P < 0.01. MDRD (Modification of Diet in Renal Disease).

Article Snippet: All patients received a continuous-flow 3 rd generation LVAD (HVAD Heartware Inc., Framingham, USA) for a severe HF at our institution.

Techniques: Modification

Journal: Scientific Reports

Article Title: Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation

doi: 10.1038/s41598-018-26515-0

Figure Lengend Snippet: ( A ) Kaplan Meier survival curve 30 days after LVAD implantation. Log rank P = 0.004. ( B ) Kaplan Meier survival curve 30 days after LVAD implantation. Log rank P = 0.003.

Article Snippet: All patients received a continuous-flow 3 rd generation LVAD (HVAD Heartware Inc., Framingham, USA) for a severe HF at our institution.

Techniques: